Clinical Trials Browser

Parkinson Disease 4, Autosomal Dominant Lewy Body, Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Ovarian Neoplasms, Stomach Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma, Triple Negative Breast Neoplasms

NCT04680988 2025-08-05

A Study of SHR-1210± SHR-1020 Versus Chemotherapy in Patients With Recurrent or Metastatic Cervical Cancer

Phase 2 Completed

194 enrolled

Gynecologic

Uterine Cervical Neoplasms, Recurrence

NCT03086681 2025-07-29

ECWHCCFLACC

Phase 2 Completed

120 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT04693234 2025-04-27

AdvanTIG-202: Anti-PD-1 Monoclonal Antibody Tislelizumab (BGB-A317) Combined With or Without Anti-TIGIT Monoclonal Antibody Ociperlimab (BGB-A1217) in Participants With Previously Treated Recurrent or Metastatic Cervical Cancer

Phase 2 Completed

178 enrolled 26 charts

Gynecologic

Uterine Cervical Neoplasms

NCT04868708 2025-03-04

A Study of AK104（ an Anti-PD-1 and Anti-CTLA-4 Bispecific Antibody) in Recurrent or Metastatic Cervical Cancer

Phase 2 Completed

50 enrolled

Gynecologic

Diabetes Mellitus, Insulin-Dependent, 12, Uterine Cervical Neoplasms, Recurrence

NCT04380805 2025-02-28

A Study of AK104, a PD-1/CTLA-4 Bispecific Antibody in Subjects With Recurrent/Metastatic Cervical Cancer

Phase 2 Completed

30 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT04870177 2025-02-28

Study of AK112 in the Treatment of Advanced Gynecological Tumors

Phase 2 Completed

53 enrolled

Gynecologic

Uterine Cervical Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Endometrial Neoplasms

NCT04357873 2025-02-19

PEVOsq

Phase 2 Completed

112 enrolled

GastrointestinalGenitourinaryGynecologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Anus Neoplasms, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Penile Neoplasms, Vulvar Neoplasms, Neoplasms, Squamous Cell

NCT04275713 2025-01-20

METOXY-LACC

Phase 2 Completed

41 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT03946358 2024-12-20

VolATIL

Phase 2 Completed

47 enrolled

GastrointestinalGynecologicHead & Neck

Anal Canal Carcinoma, Squamous Cell Carcinoma of Head and Neck, Uterine Cervical Neoplasms

NCT05227651 2024-11-01

AK104 in Neoadjuvant Treatment of Cervical Cancer

Phase 2 Completed

14 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT02009579 2024-08-07

ENGOT-cx1/BGOG-cx1: 3 Weekly Carboplatin/Paclitaxel With or Without Nintedanib in Cervix Cancer

Phase 2 Completed

120 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT04799639 2024-06-25

Efficacy and Toxicity of Paclitaxel, Cisplatin Combined With Sindilimab in NACT for Locally Advanced Cervical Cancer

Phase 2 Completed

47 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT03476798 2024-02-15

Clovis-001

Phase 2 Completed

49 enrolled 13 charts

Gynecologic

Uterine Cervical Neoplasms, Endometrial Neoplasms

NCT06226350 2024-01-26

A Phase Ⅱ Study of F520 in Patients With Cervical Carcinoma

Phase 2 Completed

29 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT04246489 2023-10-23

Bintrafusp Alfa Monotherapy in Platinum-Experienced Cervical Cancer

Phase 2 Completed

146 enrolled 20 charts

Gynecologic

Uterine Cervical Neoplasms

NCT03438396 2023-07-25

A Trial of Tisotumab Vedotin in Cervical Cancer

Phase 2 Completed

102 enrolled 20 charts 1 FDA

Gynecologic

Uterine Cervical Neoplasms

NCT02740790 2023-04-13

Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 Vaccine in Healthy Females

Phase 2 Completed

1,200 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT03073525 2023-04-05

A Trial of Atezolizumab and Vigil in Patients With Advanced Gynecological Cancers

Phase 2 Completed

25 enrolled 15 charts

Gynecologic

Uterine Cervical Neoplasms, Ovarian Neoplasms, Uterine Neoplasms

NCT03427411 2023-03-28

M7824 in Subjects With HPV Associated Malignancies

Phase 2 Completed

57 enrolled 20 charts

GastrointestinalGenitourinaryGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Oropharyngeal Neoplasms, Penile Neoplasms

NCT01399658 2023-03-14

AMIGO

Phase 2 Completed

93 enrolled 5 charts

Gynecologic

Uterine Cervical Neoplasms, Uterine Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

NCT02921269 2023-02-21

Atezolizumab and Bevacizumab in Treating Patients With Recurrent, Persistent, or Metastatic Cervical Cancer

Phase 2 Completed

11 enrolled 11 charts

Gynecologic

Uterine Cervical Neoplasms

NCT04205799 2023-02-13

CABOCOL-01

Phase 2 Completed

57 enrolled

Gynecologic

Uterine Cervical Neoplasms, Neoplasm Metastasis

NCT02025985 2023-01-26

SIGN

Phase 2 Completed

116 enrolled 21 charts

Gynecologic

Uterine Cervical Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT05694728 2023-01-23

A Phase II Trial Evaluate the Immunogenicity and Safety Profile of HPV Vaccine

Phase 2 Completed

780 enrolled

GastrointestinalGynecologic

Anus Neoplasms, Uterine Cervical Neoplasms, Condylomata Acuminata, Vulvar Neoplasms, Papillomavirus Infections

NCT01693783 2022-11-08

Ipilimumab in Treating Patients With Metastatic or Recurrent Human Papilloma Virus-Related Cervical Cancer

Phase 2 Completed

42 enrolled 12 charts

Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT00938106 2022-10-20

Optimized Magnetic Resonance Brachytherapy (MR BT) in Cervix Cancer

Phase 2 Completed

60 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT04188847 2022-03-15

First-line Chemotherapy for Recurrent Cervical Cancer

Phase 2 Completed

37 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT04188860 2022-03-15

Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy

Phase 2 Completed

34 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT03180294 2022-03-08

Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer

Phase 2 Completed

230 enrolled 24 charts

BreastGynecologic

Breast Neoplasms, Uterine Cervical Neoplasms, Ovarian Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

NCT03245736 2021-11-04

Tisotumab Vedotin Continued Treatment in Patients With Solid Tumors.

Phase 2 Completed

5 enrolled 8 charts

GastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms

NCT03192059 2021-09-08

PRIMMO

Phase 2 Completed

43 enrolled

Gynecologic

Uterine Cervical Neoplasms, Uterine Neoplasms, Endometrial Neoplasms

NCT02394652 2021-04-21

The Potential for Metformin to Improve Tumor Oxygenation in Locally Advanced Cervix Cancer: A Phase II Randomized Trial

Phase 2 Completed

16 enrolled

Gynecologic

Adenocarcinoma, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Carcinoma, Adenosquamous

NCT03935204 2021-04-08

Immunogenicity Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)

Phase 2 Completed

627 enrolled

Gynecologic

Uterine Cervical Neoplasms, Condylomata Acuminata

NCT03233412 2021-02-17

Randomized Clinical Trial Evaluating the Efficacy of Topical Imiquimod in High Grade Cervical Intraepithelial Lesions

Phase 2 Completed

90 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT02725489 2021-01-27

Pilot Study of Durvalumab and Vigil in Advanced Women's Cancers

Phase 2 Completed

13 enrolled

BreastGynecologic

Breast Neoplasms, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Uterine Neoplasms, Endometrial Neoplasms

NCT01266460 2020-09-11

Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical Cancer

Phase 2 Completed

54 enrolled 12 charts

Gynecologic

Uterine Cervical Neoplasms

NCT01928225 2020-06-24

Randomized, Double Blind Trial of the Quadrivalent HPV Vaccine to Improve Responses to LEEP Treatment of Cervical HSIL

Phase 2 Completed

180 enrolled 11 charts

Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT03540407 2020-01-23

Evaluation of Oncoxin-Viusid® in Cervical Cancer and Endometrial Adenocarcinoma.

Phase 2 Completed

66 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT00586339 2020-01-03

Safety and Immunogenicity of GlaxoSmithKline Biologicals' HPV Vaccine 580299 (Cervarix) in HIV Infected Females

Phase 2 Completed

150 enrolled 26 charts

Gynecologic

Acquired Immunodeficiency Syndrome, Uterine Cervical Neoplasms, Papillomavirus Infections

NCT00319748 2019-08-26

Study of Immune Response Modifier in the Treatment of Breast, Ovarian, Endometrial and Cervical Cancers

Phase 2 Completed

15 enrolled 12 charts

BreastGynecologic

Breast Neoplasms, Uterine Cervical Neoplasms, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT01266447 2019-08-08

Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer

Phase 2 Completed

27 enrolled 11 charts

Gynecologic

Uterine Cervical Neoplasms

NCT00025233 2019-07-24

Bevacizumab in Treating Patients With Persistent or Recurrent Cancer of the Cervix

Phase 2 Completed

50 enrolled 15 charts

Gynecologic

Uterine Cervical Neoplasms

NCT01094132 2019-07-05

MDC_Algo

Phase 2 Completed

551 enrolled

GynecologicOther neoplasm

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Precancerous Conditions

Clinical Trials

KETOCOL

SKYSCRAPER-04

Study of Anti-PD-1 Combined With Albumin-Bound Paclitaxel in Patients With Recurrent Cervical Cancer

CETUXICOL

Eribulin Mesylate in Treating Patients With Advanced or Recurrent Cervical Cancer

A Study of Patients Receiving High-Dose Rate Brachytherapy

KEYVIBE-005

A Study of SHR-1210± SHR-1020 Versus Chemotherapy in Patients With Recurrent or Metastatic Cervical Cancer

ECWHCCFLACC

AdvanTIG-202: Anti-PD-1 Monoclonal Antibody Tislelizumab (BGB-A317) Combined With or Without Anti-TIGIT Monoclonal Antibody Ociperlimab (BGB-A1217) in Participants With Previously Treated Recurrent or Metastatic Cervical Cancer

A Study of AK104（ an Anti-PD-1 and Anti-CTLA-4 Bispecific Antibody) in Recurrent or Metastatic Cervical Cancer

A Study of AK104, a PD-1/CTLA-4 Bispecific Antibody in Subjects With Recurrent/Metastatic Cervical Cancer

Study of AK112 in the Treatment of Advanced Gynecological Tumors

PEVOsq

METOXY-LACC

VolATIL

AK104 in Neoadjuvant Treatment of Cervical Cancer

ENGOT-cx1/BGOG-cx1: 3 Weekly Carboplatin/Paclitaxel With or Without Nintedanib in Cervix Cancer

Efficacy and Toxicity of Paclitaxel, Cisplatin Combined With Sindilimab in NACT for Locally Advanced Cervical Cancer

Clovis-001

A Phase Ⅱ Study of F520 in Patients With Cervical Carcinoma

Bintrafusp Alfa Monotherapy in Platinum-Experienced Cervical Cancer

A Trial of Tisotumab Vedotin in Cervical Cancer

Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 Vaccine in Healthy Females

A Trial of Atezolizumab and Vigil in Patients With Advanced Gynecological Cancers

M7824 in Subjects With HPV Associated Malignancies

AMIGO

Atezolizumab and Bevacizumab in Treating Patients With Recurrent, Persistent, or Metastatic Cervical Cancer

CABOCOL-01

SIGN

A Phase II Trial Evaluate the Immunogenicity and Safety Profile of HPV Vaccine

Ipilimumab in Treating Patients With Metastatic or Recurrent Human Papilloma Virus-Related Cervical Cancer

Optimized Magnetic Resonance Brachytherapy (MR BT) in Cervix Cancer

First-line Chemotherapy for Recurrent Cervical Cancer

Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy

Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer

Tisotumab Vedotin Continued Treatment in Patients With Solid Tumors.

PRIMMO

The Potential for Metformin to Improve Tumor Oxygenation in Locally Advanced Cervix Cancer: A Phase II Randomized Trial

Immunogenicity Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)

Randomized Clinical Trial Evaluating the Efficacy of Topical Imiquimod in High Grade Cervical Intraepithelial Lesions

Pilot Study of Durvalumab and Vigil in Advanced Women's Cancers

Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical Cancer

Randomized, Double Blind Trial of the Quadrivalent HPV Vaccine to Improve Responses to LEEP Treatment of Cervical HSIL

Evaluation of Oncoxin-Viusid® in Cervical Cancer and Endometrial Adenocarcinoma.

Safety and Immunogenicity of GlaxoSmithKline Biologicals' HPV Vaccine 580299 (Cervarix) in HIV Infected Females

Study of Immune Response Modifier in the Treatment of Breast, Ovarian, Endometrial and Cervical Cancers

Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer

Bevacizumab in Treating Patients With Persistent or Recurrent Cancer of the Cervix

MDC_Algo